Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical implications of a very late presentation in myasthenia gravis: real world experience in a tertiary center.

Arquivos de neuro-psiquiatria·2026
Same author

Oromucosal Administration of a Cannabidiol-Enriched Cannabis sp. Extract for 2 Weeks Moderately Reduces Cold Hyperalgesia in Rats With Neuropathic Pain.

European journal of pain (London, England)·2026
Same author

Esophageal dysmotility in systemic sclerosis: Relationship with extra-gastrointestinal manifestations and complementary utility of thoracic imaging.

Journal of scleroderma and related disorders·2025
Same author

The role of bone histomorphometry in the management of metabolic bone disease.

ARP rheumatology·2025
Same author

Can microvascular damage predict disease severity in patients with systemic sclerosis?

Reumatologia clinica·2024
Same author

Avacopan in an ocular complication of ANCA-PR3 vasculitis without kidney involvement.

Rheumatology (Oxford, England)·2024
Same journal

The relevance of a multidisciplinary care in the management of patients with Osteogenesis Imperfecta.

Acta reumatologica portuguesa·2021
Same journal

The Role of Medical Therapy in Refractory Pigmented Villonodular Synovitis.

Acta reumatologica portuguesa·2021
Same journal

Urticariform reaction lupus-like induced by adalimumab: a rare adverse effect.

Acta reumatologica portuguesa·2021
Same journal

Abdominal pain in Systemic Lupus Erythematosus: About a rare cause.

Acta reumatologica portuguesa·2021
Same journal

Clinical images of ENT involvement in ANCA associated Vasculitis.

Acta reumatologica portuguesa·2021
Same journal

Bone marrow edema syndrome: an unusual cause for spontaneous unrelentless bilateral knee pain.

Acta reumatologica portuguesa·2021
See all related articles

Related Experiment Video

Updated: May 30, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

Vasculitic neuropathy.

Luzia Sampaio1, Lã Gia Silva, Georgina Terroso

  • 1Serviços de Reumatologia, Hospital de São João, Faculdade de Medicina, Universidade do Porto, Portugal. luziamsampaio@gmail.com

Acta Reumatologica Portuguesa
|August 16, 2011
PubMed
Summary
This summary is machine-generated.

Vasculitic neuropathy, inflammation of peripheral nerve blood vessels, causes nerve damage. This review covers its classification, diagnosis, and treatment, including rare non-systemic forms.

More Related Videos

High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model
08:16

High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model

Published on: March 16, 2022

Related Experiment Videos

Last Updated: May 30, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model
08:16

High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model

Published on: March 16, 2022

Area of Science:

  • Neurology
  • Immunology
  • Pathology

Background:

  • Vasculitic neuropathy involves inflammation of the vasa nervorum, leading to peripheral nerve ischemia and axonal degeneration.
  • It often presents alongside systemic diseases but can be isolated to the peripheral nervous system (non-systemic vasculitic neuropathy).

Purpose of the Study:

  • To provide a comprehensive review of vasculitic neuropathy.
  • To discuss its classification, diagnostic approaches, and therapeutic strategies.

Main Methods:

  • Literature review focusing on vasculitic neuropathy.
  • Synthesis of information on classification, diagnosis, and treatment.

Main Results:

  • Vasculitic neuropathy is characterized by ischemic nerve damage due to vasculitis of the vasa nervorum.
  • It can be systemic or non-systemic, with varying clinical presentations.
  • Diagnosis relies on a combination of clinical, electrophysiological, and sometimes biopsy findings.
  • Treatment strategies vary based on the underlying cause and severity.

Conclusions:

  • Vasculitic neuropathy is a significant cause of peripheral nerve damage, often linked to systemic conditions.
  • Accurate classification, timely diagnosis, and appropriate treatment are crucial for managing this condition.
  • Further research may elucidate more targeted therapeutic options for both systemic and non-systemic forms.